Michael Hepperle
About
In The Last Decade
Michael Hepperle
25 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 75
- Oncology 482
- Molecular Biology 474
- Cancer Research 333
- Immunology 285
- Pathology and Forensic Medicine 245
Countries citing papers authored by Michael Hepperle
This map shows the geographic impact of Michael Hepperle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hepperle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hepperle more than expected).
Fields of papers citing papers by Michael Hepperle
This network shows the impact of papers produced by Michael Hepperle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hepperle. The network helps show where Michael Hepperle may publish in the future.
Co-authorship network of co-authors of Michael Hepperle
This figure shows the co-authorship network connecting the top 25 collaborators of Michael Hepperle. A scholar is included among the top collaborators of Michael Hepperle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Hepperle. Michael Hepperle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 19 | |
| 3 | 12 | |
| 4 | 101 | |
| 5 | 39 | |
| 6 | 69 | |
| 7 | 63 | |
| 8 | Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling. | 252 |
| 9 | 187 | |
| 10 | 18 | |
| 11 | 73 | |
| 12 | 22 | |
| 13 | 35 | |
| 14 | 12 | |
| 15 | Medicinal chemistry of paclitaxel: chemistry, structure-activity relationships and conformational analysis. | 4 |
| 16 | 19 | |
| 17 | 11 | |
| 18 | 11 | |
| 19 | 10 | |
| 20 | 36 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.